UNDERSTANDING DRUG RESISTANCE TO TARGETED THERAPEUTICS IN MALIGNANT B-CELL LYMPHOPROLIFERATIVE DISORDERS (CA120064)

$308,400FY2013Department of DefenseDOD

Duke University, Durham NC

Investigators